ARBUTUS BIOPHARMA overview

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arbutus Biopharma Corporation - ABUS PR Newswire NEW YORK, May 10, 2023 NEW YORK , May 10, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Arbutus Biopharma Corporation ("Arbutus" or the "Company") (NASDAQ: ABUS). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Arbutus and certain...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arbutus Biopharma Corporation - ABUS PR Newswire NEW YORK, May 2, 2023 NEW YORK , May 2, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Arbutus Biopharma Corporation ("Arbutus" or the "Company") (NASDAQ: ABUS). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Arbutus and certain...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arbutus Biopharma Corporation - ABUS PR Newswire NEW YORK, April 26, 2023 NEW YORK , April 26, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Arbutus Biopharma Corporation ("Arbutus" or the "Company") (NASDAQ: ABUS). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Arbutus and...

Thinking about buying stock in Renewable Energy, First Horizon, Indonesia Energy, Arbutus Biopharma, or Arcimoto? PR Newswire NEW YORK, Feb. 28, 2022 NEW YORK , Feb. 28, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for REGI, FHN, INDO, ABUS, and FUV. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. REGI:...

Thinking about buying stock in Arrival SA, Clover Health Investments, Arbutus Biopharma, Aterian, or Brinker International? PR Newswire NEW YORK, Feb. 2, 2022 NEW YORK , Feb. 2, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ARVL, CLOV, ABUS, ATER, and EAT. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. ARVL:...

Thinking about buying stock in Lucid Group, Energy Transfer, Ardelyx, Inspira Technologies, or Arbutus Biopharma? PR Newswire NEW YORK, Dec. 10, 2021 NEW YORK , Dec. 10, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for LCID, ET, ARDX, IINN, and ABUS. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. LCID:...

Thinking about buying stock in Phunware, Omeros Corp, Humanigen, Spirit AeroSystems, or Arbutus Biopharma? PR Newswire NEW YORK, Dec. 2, 2021 NEW YORK , Dec. 2, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PHUN, OMER, HGEN, SPR, and ABUS. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. PHUN:...

Thinking about buying stock in Arbutus Biopharma, Aemetis, FuboTV, Rubius Therapeutics, or Lithium Americas Corp? PR Newswire NEW YORK, April 1, 2021 NEW YORK , April 1, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ABUS, AMTX, FUBO, RUBY, and LAC. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. ABUS:...